ω-3 fatty acids and cardiovascular diseases: Effects, mechanisms and dietary relevance

International Journal of Molecular Sciences

Volumn 16, Issue 9, 2015, Pages 22636-22661

  Maehre, Hanne K ^a   Jensen, Ida Johanne ^a   Elvevoll, Edel O ^a   Eilertsen, Karl Erik ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Cardiovascular diseases; Docosahexaenoic acid (DHA); Eicosapentaenoic acids (EPA); Lipid peroxidation; N 3 fatty acids; Seafood; Supplements

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR; CYCLOOXYGENASE 2; CYTOCHROME P450; GAMMA INTERFERON; ICOSANOID; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; PROSTAGLANDIN SYNTHASE; SELECTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID;

ANGIOGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL MIGRATION; CELL PROLIFERATION; COMORBIDITY; DIETARY INTAKE; HEART PROTECTION; LIPID PEROXIDATION; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SEA FOOD; ANALYSIS; ANIMAL; CARDIOVASCULAR DISEASES; DIET; DIETARY SUPPLEMENT; HUMAN; METABOLISM;

ANIMALS; CARDIOVASCULAR DISEASES; DIET; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HUMANS; LIPID PEROXIDATION; SEAFOOD;

EID: 84942154972     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160922636     Document Type: Review

References (143)

1. Bang, H.O.; Dyerberg, J.; Hjorne, N. Composition of food consumed by greenland eskimos. Acta Med. Scand.1976, 200, 69–73.
2. Bang, H.O.; Dyerberg, J.; Nielsen, A.B. Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet 1971, 1, 1143–1145.
3. Dyerberg, J.; Bang, H.O. Hemostatic function and platelet poly-unsaturated fatty acids in eskimos. Lancet 1979, 2, 433–435.
4. Dyerberg, J.; Bang, H.O.; Stoffersen, E.; Moncada, S.; Vane, J.R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978, 2, 117–119.
5. Bjerregaard, P.; Young, T.K.; Hegele, R.A. Low incidence of cardiovascular disease among the inuit-what is the evidence? Atherosclerosis 2003, 166, 351–357.
6. Fodor, J.G.; Helis, E.; Yazdekhasti, N.; Vohnout, B. “Fishing” for the origins of the “Eskimos and heart disease” Story: Facts or wishful thinking? Can. J. Cardiol. 2014, 30, 864–868.
7. Cardiovascular diseases (CVDs): Fact sheet no. 317; World Health Organization: Geneva, Switzerland. Available online: http://www.who.int/mediacentre/factsheets/fs317/en/index.html (accessed on 15 August 2015).
8. Mendis, S.; Puska, P.; Norrving, B. Global Atlas on Cardiovascular Disease Prevention and Control; Mendis, S., Puska, P., Eds.; World Health Organization: Geneva, Switzerland, 2011.
9. Yusuf, H.R.; Giles, W.H.; Croft, J.B.; Anda, R.F.; Casper, M.L. Impact of multiple risk factor profiles on determining cardiovascular disease risk. Prev. Med. 1998, 27, 1–9.
10. Galley, H.F.; Webster, N.R. Physiology of the endothelium. Br. J. Anaesth.2004, 93, 105–113.
11. Bonetti, P.O.; Lerman, L.O.; Lerman, A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 168–175.
12. McLaren, J.E.; Michael, D.R.; Ashlin, T.G.; Ramji, D.P. Cytokines, macrophage lipid metabolism and foam cells: Implications for cardiovascular disease therapy. Prog. Lipid Res. 2011, 50, 331–347.
13. Szmitko, P.E.; Wang, C.H.; Weisel, R.D.; de Almeida, J.R.; Anderson, T.J.; Verma, S. New markers of inflammation and endothelial cell activation: Part I. Circulation 2003, 108, 1917–1923.
14. Smith, W.L.; Murphy, R.C. The eicosanoids: Cyclooxygenase, lipoxygenase, and epoxygenase pathways. In Biochemistry of Lipids, Lipoproteins and Membranes, 5th ed.; Vance, D.E., Vance, J.E., Eds.; Elsevier B.V.: Amsterdam, The Netherlands, 2008.
15. Bannenberg, G.; Serhan, C.N. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim. Biophys. Acta 2010, 1801, 1260–1273.
16. Larsson, S.C.; Kumlin, M.; Ingelman-Sundberg, M.; Wolk, A. Dietary long-chain n-3 fatty acids for the prevention of cancer: A review of potential mechanisms. Am. J. Clin. Nutr. 2004, 79, 935–945.
17. Calder, P.C. Marine ω-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim. Biophys. Acta 2015, 1851, 469–484.
18. Serhan, C.N. Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 2007, 25, 101–137.
19. Stables, M.J.; Gilroy, D.W. Old and new generation lipid mediators in acute inflammation and resolution. Prog. Lipid Res. 2011, 50, 35–51.
20. Morita, I. Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat. 2002, 68–69, 165–175.
21. Smith, W.L.; Langenbach, R. Why there are two cyclooxygenase isozymes. J. Clin. Investig. 2001, 107, 1491–1495.
22. Simmons, D.L. Variants of cyclooxygenase-1 and their roles in medicine. Thromb. Res. 2003, 110, 265–268.
23. Barbosa-Sicard, E.; Markovic, M.; Honeck, H.; Christ, B.; Muller, D.N.; Schunck, W.H. Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily. Biochem. Biophys. Res. Commun. 2005, 329, 1275–1281.
24. Arnold, C.; Konkel, A.; Fischer, R.; Schunck, W.H. Cytochrome P450-dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids. Pharmacol. Rep. 2010, 62, 536–547.
25. Pratico, D.; Dogne, J.M. Vascular biology of eicosanoids and atherogenesis. Expert Rev. Cardiovasc. Ther. 2009, 7, 1079–1089.
26. Simopoulos, A.P. The importance of the ω-6/ω-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med.2008, 233, 674–688.
27. Friedrich, E.B.; Tager, A.M.; Liu, E.; Pettersson, A.; Owman, C.; Munn, L.; Luster, A.D.; Gerszten, R.E. Mechanisms of leukotriene B-4-triggered monocyte adhesion. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1761–1767.
28. Huang, L.; Zhao, A.; Wong, F.; Ayala, J.M.; Struthers, M.; Ujjainwalla, F.; Wright, S.D.; Springer, M.S.; Evans, J.; Cui, J.S. Leukotriene B-4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1783–1788.
29. Moreno, J.J. Differential effects of arachidonic and eicosapentaenoic acid-derived eicosanoids on polymorphonuclear transmigration across endothelial cell cultures. J. Pharmacol. Exp. Ther. 2009, 331, 1111–1117.
30. Yates, C.M.; Calder, P.C.; Rainger, G.E. Pharmacology and therapeutics of ω-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol. Ther.2014, 141, 272–282.
31. Oliver, E.; McGillicuddy, F.C.; Harford, K.A.; Reynolds, C.M.; Phillips, C.M.; Ferguson, J.F.; Roche, H.M. Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. J. Nutr. Biochem. 2012, 23, 1192–1200.
32. Yagi, S.; Aihara, K.; Fukuda, D.; Takashima, A.; Hara, T.; Hotchi, J.; Ise, T.; Yamaguchi, K.; Tobiume, T.; Iwase, T. et al. Effects of docosahexaenoic acid on the endothelial function in patients with coronary artery disease. J. Atheroscler. Thromb. 2015, 22, 447–454.
33. Qu, Q.; Xuan, W.; Fan, G.H. Roles of resolvins in the resolution of acute inflammation. Cell Biol. Int.2015, 39, 3–22.
34. Ayala, A.; Munoz, M.F.; Arguelles, S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev. 2014, 2014, doi:10.1155/2014/360438.
35. Esterbauer, H.; Schaur, R.J.; Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11, 81–128.
36. Riahi, Y.; Cohen, G.; Shamni, O.; Sasson, S. Signaling and cytotoxic functions of 4-hydroxyalkenals. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E879–E886.
37. Van den Berg, R.; Haenen, G.R.M.M.; van den Berg, H.; Bast, A. Transcription factor NF-κB as a potential biomarker for oxidative stress. Br. J. Nutr.2001, 86, S121–S127.
38. Esterbauer, H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr. 1993, 57, 779–786.
39. Long, E.K.; Murphy, T.C.; Leiphon, L.J.; Watt, J.; Morrow, J.D.; Milne, G.L.; Howard, J.R.; Picklo, M.J., Sr. Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation. J. Neurochem. 2008, 105, 714–724.
40. Je, J.H.; Lee, J.Y.; Jung, K.J.; Sung, B.; Go, E.K.; Yu, B.P.; Chung, H.Y. NF-κB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway. FEBS Lett. 2004, 566, 183–189.
41. Ishikado, A.; Nishio, Y.; Morino, K.; Ugi, S.; Kondo, H.; Makino, T.; Kashiwagi, A.; Maegawa, H. Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells. Biochem. Biophys. Res. Commun. 2010, 402, 99–104.
42. Uchida, K. Role of reactive aldehyde in cardiovascular diseases. Free Radic. Biol. Med. 2000, 28, 1685–1696.
43. Yamada, S.; Funada, T.; Shibata, N.; Kobayashi, M.; Kawai, Y.; Tatsuda, E.; Furuhata, A.; Uchida, K. Protein-bound 4-hydroxy-2-hexenal as a marker of oxidized n-3 polyunsaturated fatty acids. J. Lipid Res.2004, 45, 626–634.
44. Flock, M.R.; Skulas-Ray, A.C.; Harris, W.S.; Etherton, T.D.; Fleming, J.A.; Kris-Etherton, P.M. Determinants of erythrocyte ω-3 fatty acid content in response to fish oil supplementation: A dose-response randomized controlled trial. J. Am. Heart Assoc.2013, 2, e000513.
45. Keenan, A.H.; Pedersen, T.L.; Fillaus, K.; Larson, M.K.; Shearer, G.C.; Newman, J.W. Basal ω-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n-3-HUFA in healthy volunteers. J. Lipid Res.2012, 53, 1662–1669.
46. Harris, W.S.; von Schacky, C. The ω-3 index: A new risk factor for death from coronary heart disease? Prev. Med. 2004, 39, 212–220.
47. Von Schacky, C. ω-3 index and cardiovascular health. Nutrients 2014, 6, 799–814.
48. Harris, W.S. The ω-3 index: From biomarker to risk marker to risk factor. Curr. Atheroscler. Rep. 2009, 11, 411–417.
49. Maaloe, T.; Schmidt, E.B.; Svensson, M.; Aardestrup, I.V.; Christensen, J.H. The effect of n-3 polyunsaturated fatty acids on leukotriene B4 and leukotriene B5 production from stimulated neutrophil granulocytes in patients with chronic kidney disease. Prostaglandins Leukot. Essent. Fatty Acids 2011, 85, 37–41.
50. Raatz, S.K.; Young, L.R.; Picklo, M.J., Sr.; Sauter, E.R.; Qin, W.; Kurzer, M.S. Total dietary fat and fatty acid content modifies plasma phospholipid fatty acids, desaturase activity indices, and urinary prostaglandin E in women. Nutr. Res. 2012, 32, 1–7.
51. Stanke-Labesque, F.; Moliere, P.; Bessard, J.; Laville, M.; Vericel, E.; Lagarde, M. Effect of dietary supplementation with increasing doses of docosahexaenoic acid on neutrophil lipid composition and leukotriene production in human healthy volunteers. Br. J. Nutr.2008, 100, 829–833.
52. Fischer, R.; Konkel, A.; Mehling, H.; Blossey, K.; Gapelyuk, A.; Wessel, N.; von Schacky, C.; Dechend, R.; Muller, D.N.; Rothe, M. et al. Dietary ω-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway. J. Lipid Res.2014, 55, 1150–1164.
53. Arnold, C.; Markovic, M.; Blossey, K.; Wallukat, G.; Fischer, R.; Dechend, R.; Konkel, A.; von Schacky, C.; Luft, F.C.; Muller, D.N. et al.Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of ω3 fatty acids. J. Biol. Chem. 2010, 285, 32720–32733.
54. Watanabe, N.; Watanabe, Y.; Kumagai, M.; Fujimoto, K. Administration of dietary fish oil capsules in healthy middle-aged Japanese men with a high level of fish consumption. Int. J. Food Sci. Nutr. 2009, 60 (Suppl. 5), 136–142.
55. Ciubotaru, I.; Lee, Y.S.; Wander, R.C. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J. Nutr. Biochem.2003, 14, 513–521.
56. Kiecolt-Glaser, J.K.; Belury, M.A.; Andridge, R.; Malarkey, W.B.; Glaser, R. ω-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial. Brain Behav. Immun. 2011, 25, 1725–1734.
57. Kiecolt-Glaser, J.K.; Belury, M.A.; Andridge, R.; Malarkey, W.B.; Hwang, B.S.; Glaser, R. ω-3 supplementation lowers inflammation in healthy middle-aged and older adults: A randomized controlled trial. Brain Behav. Immun. 2012, 26, 988–995.
58. Moertl, D.; Hammer, A.; Steiner, S.; Hutuleac, R.; Vonbank, K.; Berger, R. Dose-dependent effects of ω-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: A double-blind, placebo-controlled, 3-arm study. Am. Heart J. 2011, 161, doi:10.1016/j.ahj.2011.02.011.
59. Nodari, S.; Triggiani, M.; Campia, U.; Manerba, A.; Milesi, G.; Cesana, B.M.; Gheorghiade, M.; Cas, L.D. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. 2011, 57, 870–879.
60. Zhao, Y.T.; Shao, L.; Teng, L.L.; Hu, B.; Luo, Y.; Yu, X.; Zhang, D.F.; Zhang, H. Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure. J. Int. Med. Res. 2009, 37, 1831–1841.
61. Elvevoll, E.O.; Eilertsen, K.E.; Brox, J.; Dragnes, B.T.; Falkenberg, P.; Olsen, J.O.; Kirkhus, B.; Lamglait, A.; Osterud, B. Seafood diets: Hypolipidemic and antiatherogenic effects of taurine and n-3 fatty acids. Atherosclerosis 2008, 200, 396–402.
62. Juarez-Lopez, C.; Klunder-Klunder, M.; Madrigal-Azcarate, A.; Flores-Huerta, S. ω-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents. Pediatr. Diabetes 2013, 14, doi:10.1111/pedi.12024.
63. Zhang, J.; Wang, C.; Li, L.; Man, Q.; Meng, L.; Song, P.; Froyland, L.; Du, Z.Y. Dietary inclusion of salmon, herring and pompano as oily fish reduces CVD risk markers in dyslipidaemic middle-aged and elderly Chinese women. Br. J. Nutr.2012, 108, 1455–1465.
64. Zhang, J.; Wang, C.; Li, L.; Man, Q.; Song, P.; Meng, L.; Du, Z.Y.; Froyland, L. Inclusion of atlantic salmon in the Chinese diet reduces cardiovascular disease risk markers in dyslipidemic adult men. Nutr. Res. 2010, 30, 447–454.
65. Baldassarre, D.; Amato, M.; Eligini, S.; Barbieri, S.S.; Mussoni, L.; Frigerio, B.; Kozakova, M.; Tremoli, E.; Sirtori, C.R.; Colli, S. Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: A double-blind pilot study in primary prevention. Ann. Med. 2006, 38, 367–375.
66. Ramprasath, V.R.; Eyal, I.; Zchut, S.; Jones, P.J. Enhanced increase of ω-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil vs. fish oil. Lipids Health Dis. 2013, 12, doi:10.1186/1476-511X-12-178.
67. Ishida, T.; Ohta, M.; Nakakuki, M.; Kami, H.; Uchiyama, R.; Kawano, H.; Notsu, T.; Imada, K.; Shimano, H. Distinct regulation of plasma LDL cholesterol by eicosapentaenoic acid and docosahexaenoic acid in high fat diet-fed hamsters: Participation of cholesterol ester transfer protein and LDL receptor. Prostaglandins Leukot. Essent. Fatty Acids 2013, 88, 281–288.
68. Root, M.; Collier, S.R.; Zwetsloot, K.A.; West, K.L.; McGinn, M.C. A randomized trial of fish oil ω-3 fatty acids on arterial health, inflammation, and metabolic syndrome in a young healthy population. Nutr. J. 2013, 12, doi:10.1186/1475-2891-12-40.
69. Garaiova, I.; Muchova, J.; Nagyova, Z.; Mislanova, C.; Oravec, S.; Dukat, A.; Wang, D.; Plummer, S.F.; Durackova, Z. Effect of a plant sterol, fish oil and B vitamin combination on cardiovascular risk factors in hypercholesterolemic children and adolescents: A pilot study. Nutr. J.2013, 12, doi:10.1186/1475-2891-12-7.
70. Paoli, A.; Moro, T.; Bosco, G.; Bianco, A.; Grimaldi, K.A.; Camporesi, E.; Mangar, D. Effects of n-3 polyunsaturated fatty acids (ω-3) supplementation on some cardiovascular risk factors with a ketogenic Mediterranean diet. Mar. Drugs 2015, 13, 996–1009.
71. Iketani, T.; Takazawa, K.; Yamashina, A. Effect of eicosapentaenoic acid on central systolic blood pressure. Prostaglandins Leukot. Essent. Fatty Acids 2013, 88, 191–195.
72. Ramel, A.; Martinez, J.A.; Kiely, M.; Bandarra, N.M.; Thorsdottir, I. Moderate consumption of fatty fish reduces diastolic blood pressure in overweight and obese European young adults during energy restriction. Nutrition 2010, 26, 168–174.
73. Rasmussen, B.M.; Vessby, B.; Uusitupa, M.; Berglund, L.; Pedersen, E.; Riccardi, G.; Rivellese, A.A.; Tapsell, L.; Hermansen, K.; Group, K.S. Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects. Am. J. Clin. Nutr. 2006, 83, 221–226.
74. Campbell, F.; Dickinson, H.O.; Critchley, J.A.; Ford, G.A.; Bradburn, M. A systematic review of fish-oil supplements for the prevention and treatment of hypertension. Eur. J. Prev. Cardiol. 2013, 20, 107–120.
75. Miller, P.E.; van Elswyk, M.; Alexander, D.D. Long-chain ω-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: A meta-analysis of randomized controlled trials. Am. J. Hypertens. 2014, 27, 885–896.
76. Awada, M.; Soulage, C.O.; Meynier, A.; Debard, C.; Plaisancie, P.; Benoit, B.; Picard, G.; Loizon, E.; Chauvin, M.A.; Estienne, M. et al. Dietary oxidized n-3 PUFA induce oxidative stress and inflammation: Role of intestinal absorption of 4-HHE and reactivity in intestinal cells. J. Lipid Res. 2012, 53, 2069–2080.
77. Lu, T.; Harper, A.F.; Zhao, J.; Dalloul, R.A. Effects of a dietary antioxidant blend and vitamin E on growth performance, oxidative status, and meat quality in broiler chickens fed a diet high in oxidants. Poult. Sci. 2014, 93, 1649–1657.
78. Lu, T.; Harper, A.F.; Zhao, J.; Estienne, M.J.; Dalloul, R.A. Supplementing antioxidants to pigs fed diets high in oxidants: I. Effects on growth performance, liver function, and oxidative status. J. Anim. Sci. 2014, 92, 5455–5463.
79. Yang, S.P.; Liu, H.L.; Wang, C.G.; Yang, P.; Sun, C.B.; Chan, S.M. Effect of oxidized fish oil on growth performance and oxidative stress of Litopenaeus vannamei. Aquac. Nutr. 2015, 21, 121–127.
80. Eilertsen, K.E.; Maehre, H.K.; Cludts, K.; Olsen, J.O.; Hoylaerts, M.F. Dietary enrichment of apolipoprotein E-deficient mice with extra virgin olive oil in combination with seal oil inhibits atherogenesis. Lipids Health Dis. 2011, 10, 1–8.
81. Eilertsen, K.E.; Maehre, H.K.; Jensen, I.J.; Devold, H.; Olsen, J.O.; Lie, R.K.; Brox, J.; Berg, V.; Elvevoll, E.O.; Osterud, B. A wax ester and astaxanthin-rich extract from the marine copepod Calanus finmarchicus attenuates atherogenesis in female apolipoprotein E-deficient mice. J. Nutr. 2012, 142, 508–512.
82. Ottestad, I.; Vogt, G.; Retterstol, K.; Myhrstad, M.C.; Haugen, J.E.; Nilsson, A.; Ravn-Haren, G.; Nordvi, B.; Bronner, K.W.; Andersen, L.F. et al. Oxidised fish oil does not influence established markers of oxidative stress in healthy human subjects: A randomised controlled trial. Br. J. Nutr.2012, 108, 315–326.
83. Garcia-Hernandez, V.M.; Gallar, M.; Sanchez-Soriano, J.; Micol, V.; Roche, E.; Garcia-Garcia, E. Effect of ω-3 dietary supplements with different oxidation levels in the lipidic profile of women: A randomized controlled trial. Int. J. Food Sci. Nutr. 2013, 64, 993–1000.
84. Asghari, L.; Zeynali, F.; Sahari, M.A. Effects of boiling, deep-frying, and microwave treatment on the proximate composition of rainbow trout fillets: Changes in fatty acids, total protein, and minerals. J. Appl. Ichthyol. 2013, 29, 847–853.
85. Mierke-Klemeyer, S.; Larsen, R.; Oehlenschlager, J.; Maehre, H.; Elvevoll, E.O.; Bandarra, N.M.; Parreira, R.; Andrade, A.M.; Nunes, M.L.; Schram, E. et al. Retention of health-related beneficial components during household preparation of selenium-enriched African catfish (Clarias gariepinus) fillets. Eur. Food Res. Technol. 2008, 227, 827–833.
86. Perez-Palacios, T.; Petisca, C.; Casal, S.; Ferreira, I.M.P.L.V.O. Changes in chemical composition of frozen coated fish products during deep-frying. Int. J. Food Sci. Nutr. 2014, 65, 212–218.
87. Pirini, M.; Testi, S.; Ventrella, V.; Pagliarani, A.; Badiani, A. Blue-back fish: Fatty acid profile in selected seasons and retention upon baking. Food Chem. 2010, 123, 306–314.
88. Weichselbaum, E.; Coe, S.; Buttriss, J.; Stanner, S. Fish in the diet: A review. Nutr. Bull. 2013, 38, 128–177.
89. Larsen, R.; Eilertsen, K.E.; Maehre, H.K.; Jensen, I.J.; Elvevoll, E.O. Taurine content in marine foods—Beneficial health effects. In Bioactive Compounds from Marine Foods: Plant and Animal Sources; Hernández-Ledesma, B., Herrero, M., Eds.; Wiley-Blackwell Oxford: Chichester, UK, 2014; pp. 249–268.
90. Jensen, I.J.; Abrahamsen, H.; Maehre, H.K.; Elvevoll, E.O. Changes in antioxidative capacity of saithe (Pollachius virens) and Shrimp (Pandalus borealis) during in vitro digestion. J. Agric. Food Chem. 2009, 57, 10928–10932.
91. Skåre, J.U.; Brantsæter, A.L.; Frøyland, L.; Hemre, G.L.; Knutsen, H.K.; Lillegaard, I.T.L.; Torstensen, B. Benefit-risk assessment of fish and fish products in the Norwegian diet—An update. Eur. J. Nutr. Food Saf. 2015, 5, 260–266.
92. Oterhals, A.; Kvamme, B.; Berntssen, M.H. Modeling of a short-path distillation process to remove persistent organic pollutants in fish oil based on process parameters and quantitative structure properties relationships. Chemosphere 2010, 80, 83–92.
93. Oterhals, A.; Berntssen, M.H. Effects of refining and removal of persistent organic pollutants by short-path distillation on nutritional quality and oxidative stability of fish oil. J. Agric. Food Chem. 2010, 58, 12250–12259.
94. Wang, H.; Liu, F.; Yang, L.; Zu, Y.G.; Wang, H.; Qu, S.Z.; Zhang, Y. Oxidative stability of fish oil supplemented with carnosic acid compared with synthetic antioxidants during long-term storage. Food Chem. 2011, 128, 93–99.
95. Zuta, P.C.; Simpson, B.K.; Zhao, X.; Leclerc, L. The effect of α-tocopherol on the oxidation of mackerel oil. Food Chem. 2007, 100, 800–807.
96. Ahn, J.H.; Kim, Y.P.; Seo, E.M.; Choi, Y.K.; Kim, H.S. Antioxidant effect of natural plant extracts on the microencapsulated high oleic sunflower oil. J. Food Eng. 2008, 84, 327–334.
97. Kagami, Y.; Sugimura, S.; Fujishima, N.; Matsuda, K.; Kometani, T.; Matsumura, Y. Oxidative stability, structure, and physical characteristics of microcapsules formed by spray drying of fish oil with protein and dextrin wall materials. J. Food Sci. 2003, 68, 2248–2255.
98. Bottcher, S.; Steinhauser, U.; Drusch, S. Off-flavour masking of secondary lipid oxidation products by pea dextrin. Food Chem. 2015, 169, 492–498.
99. Kralovec, J.A.; Zhang, S.C.; Zhang, W.; Barrow, C.J. A review of the progress in enzymatic concentration and microencapsulation of ω-3 rich oil from fish and microbial sources. Food Chem. 2012, 131, 639–644.
100. Ritter, J.C.S.; Budge, S.M.; Jovica, F.; Reid, A.J.M. Oxidation rates of triacylglycerol and ethyl ester fish oils. J. Am. Oil Chem. Soc. 2015, 92, 561–569.
101. Bosch, J.; Gerstein, H.C.; Dagenais, G.R.; Diaz, R.; Dyal, L.; Jung, H.; Maggiono, A.P.; Probstfield, J.; Ramachandran, A.; Riddle, M.C. et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N. Engl. J. Med. 2012, 367, 309–318.
102. Chrysohoou, C.; Panagiotakos, D.B.; Pitsavos, C.; Skoumas, J.; Krinos, X.; Chloptsios, Y.; Nikolaou, V.; Stefanadis, C. Long-term fish consumption is associated with protection against arrhythmia in healthy persons in a Mediterranean region—The ATTICA study. Am. J. Clin. Nutr. 2007, 85, 1385–1391.
103. Mozaffarian, D.; Marchioli, R.; Macchia, A.; Silletta, M.G.; Ferrazzi, P.; Gardner, T.J.; Latini, R.; Libby, P.; Lombardi, F.; O’Gara, P.T. et al. Fish oil and postoperative atrial fibrillation the ω-3 fatty acids for prevention of post-operative atrial fibrillation (OPERA) randomized trial. JAMA 2012, 308, 2001–2011.
104. Roncaglioni, M.C.; Tombesi, M.; Avanzini, F.; Barlera, S.; Caimi, V.; Longoni, P.; Marzona, I.; Milani, V.; Silletta, M.G.; Tognoni, G. et al. n-3 fatty acids in patients with multiple cardiovascular risk factors. N. Engl. J. Med.2013, 368, 1800–1808.
105. Tavazzi, L.; Maggioni, A.P.; Marchioli, R.; Barlera, S.; Franzosi, M.G.; Latini, R.; Lucci, D.; Nicolosi, G.L.; Porcu, M.; Tognoni, G.; et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial. Lancet 2008, 372, 1223–1230.
106. Virtanen, J.K.; Mozaffarian, D.; Chiuve, S.E.; Rimm, E.B. Fish consumption and risk of major chronic disease in men. Am. J. Clin. Nutr. 2008, 88, 1618–1625.
107. Yokoyama, M.; Origasa, H.; Matsuzaki, M.; Matsuzawa, Y.; Saito, Y.; Ishikawa, Y.; Oikawa, S.; Sasaki, J.; Hishida, H.; Itakura, H. et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised openlabel, blinded endpoint analysis. Lancet 2007, 369, 1090–1098.
108. Zheng, J.; Huang, T.; Yu, Y.; Hu, X.; Yang, B.; Li, D. Fish consumption and CHD mortality: An updated meta-analysis of seventeen cohort studies. Public. Health Nutr. 2012, 15, 725–737.
109. Bernstein, A.M.; Sun, Q.; Hu, F.B.; Stampfer, M.J.; Manson, J.E.; Willett, W.C. Major dietary protein sources and risk of coronary heart disease in women. Circulation 2010, 122, 876–883.
110. Djousse, L.; Akinkuolie, A.O.; Wu, J.H.Y.; Ding, E.L.; Gaziano, J.M. Fish consumption, ω-3 fatty acids and risk of heart failure: A meta-analysis. Clin. Nutr. 2012, 31, 846–853.
111. Chowdhury, R.; Stevens, S.; Gorman, D.; Pan, A.; Warnakula, S.; Chowdhury, S.; Ward, H.; Johnson, L.; Crowe, F.; Hu, F.B. et al. Association between fish consumption, long chain ω-3 fatty acids, and risk of cerebrovascular disease: Systematic review and meta-analysis. BMJ 2012, 345, e6698.
112. Li, Y.H.; Zhou, C.H.; Pei, H.J.; Zhou, X.L.; Li, L.H.; Wu, Y.J.; Hui, R.T. Fish consumption and incidence of heart failure: A meta-analysis of prospective cohort studies. Chin. Med. J. 2013, 126, 942–948.
113. Xun, P.; Qin, B.; Song, Y.; Nakamura, Y.; Kurth, T.; Yaemsiri, S.; Djousse, L.; He, K. Fish consumption and risk of stroke and its subtypes: Accumulative evidence from a meta-analysis of prospective cohort studies. Eur. J. Clin. Nutr. 2012, 66, 1199–1207.
114. Yinko, S.S.L.L.; Stark, K.D.; Thanassoulis, G.; Pilote, L. Fish consumption and acute coronary syndrome: A meta-analysis. Am. J. Med. 2014, 127, 848–852.
115. Musa-Veloso, K.; Binns, M.A.; Kocenas, A.; Chung, C.; Rice, H.; Oppedal-Olsen, H.; Lloyd, H.; Lemke, S. Impact of low v. moderate intakes of long-chain n-3 fatty acids on risk of coronary heart disease. Br. J. Nutr.2011, 106, 1129–1141.
116. Delgado-Lista, J.; Perez-Martinez, P.; Lopez-Miranda, J.; Perez-Jimenez, F. Long chain ω-3 fatty acids and cardiovascular disease: A systematic review. Br. J. Nutr.2012, 107 (Suppl. 2), S201–S213.
117. Rizos, E.C.; Ntzani, E.E.; Bika, E.; Kostapanos, M.S.; Elisaf, M.S. Association between ω-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA 2012, 308, 1024–1033.
118. Casula, M.; Soranna, D.; Catapano, A.L.; Corrao, G. Long-term effect of high dose ω-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials. Atheroscler. Suppl. 2013, 14, 243–251.
119. Zheng, T.; Zhao, J.; Wang, Y.; Liu, W.; Wang, Z.; Shang, Y.; Zhang, W.; Zhang, Y.; Zhong, M. The limited effect of ω-3 polyunsaturated fatty acids on cardiovascular risk in patients with impaired glucose metabolism: A meta-analysis. Clin. Biochem. 2014, 47, 369–377.
120. Wen, Y.T.; Dai, J.H.; Gao, Q. Effects of ω-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: A meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 470–475.
121. Enns, J.E.; Yeganeh, A.; Zarychanski, R.; Abou-Setta, A.M.; Friesen, C.; Zahradka, P.; Taylor, C.G. The impact of ω-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: A systematic review and meta-analysis. BMC Cardiovasc. Disord. 2014, 14, doi:10.1186/1471-2261-14-70.
122. Burr, M.L.; Gilbert, J.F.; Holliday, R.M.; Elwood, P.C.; Fehily, A.M.; Rogers, S.; Sweetnam, P.M.; Deadman, N.M. Effects of changes in fat, fish, and fiber intakes on death and myocardial reinfarction—Diet and reinfarction trial (DART). Lancet 1989, 2, 757–761.
123. Valagussa, F.; Franzosi, M.G.; Geraci, E.; Mininni, N.; Nicolosi, G.L.; Santini, M.; Tavazzi, L.; Vecchio, C.; Marchioli, R.; Bomba, E. et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 1999, 354, 447–455.
124. FAO (2014); The state of world fisheries and aquaculture 2014 (Online). The Food and Agriculture Organization of the United Nations, Rome, Italy. Available online: http://www.fao.org/3/a-i3720e.pdf (accessed on 10 August 2015).
125. Mozaffarian, D.; Rimm, E.B. Fish intake, contaminants, and human health—Evaluating the risks and the benefits. JAMA 2006, 296, 1885–1899.
126. Hohmann, C.D.; Cramer, H.; Michalsen, A.; Kessler, C.; Steckhan, N.; Choi, K.; Dobos, G. Effects of high phenolic olive oil on cardiovascular risk factors: A systematic review and meta-analysis. Phytomedicine 2015, 22, 631–640.
127. Albert, B.B.; Cameron-Smith, D.; Hofman, P.L.; Cutfield, W.S. Oxidation of marine ω-3 supplements and human health. Biomed. Res. Int. 2013, 2013, doi:10.1155/2013/464921.
128. Albert, B.B.; Derraik, J.G.B.; Cameron-Smith, D.; Hofman, P.L.; Tumanov, S.; Villas-Boas, S.G.; Garg, M.L.; Cutfield, W.S. Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA. Sci. Rep.2015, 5, doi:10.1038/srep07928.
129. Halvorsen, B.L.; Blomhoff, R. Determination of lipid oxidation products in vegetable oils and marineω-3 supplements. Food Nutr. Res. 2011, 55, doi:10.3402/fnr.v55i0.5792.
130. Opperman, M.; Benade, S. Analysis of the ω-3 fatty acid content of South African fish oil supplements: A follow-up study. Cardiovasc. J. Afr. 2013, 24, 297–302.
131. Kleiner, A.C.; Cladis, D.P.; Santerre, C.R. A comparison of actual vs. stated label amounts of EPA and DHA in commercial ω-3 dietary supplements in the United States. J. Sci. Food Agric. 2015, 95, 1260–1267.
132. Simopoulos, A.P. Evolutionary aspects of diet: The ω-6/ω-3 ratio and the brain. Mol. Neurobiol. 2011, 44, 203–215.
133. Simopoulos, A.P. The importance of the ratio of ω-6/ω-3 essential fatty acids. Biomed. Pharmacother. 2002, 56, 365–379.
134. Calder, P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83, 1505S–1519S.
135. Patterson, E.; Wall, R.; Fitzgerald, G.F.; Ross, R.P.; Stanton, C. Health implications of high dietary ω-6 polyunsaturated Fatty acids. J. Nutr. Metab. 2012, 2012, doi:10.1155/2012/539426.
136. FAO/WHO. Report of the Joint FAO/WHO Expert Consultation on the Risks and Benefits of Fish Consumption. Food and Agriculture Organization of the United Nations; World Health Organization: Rome, Italy; Geneva, Switzerland, 2011.
137. AHA (2015); AHA recommendation (Online). The American Heart Association, Dallas, TX, USA. Available online: http://www.heart.org/HEARTORG/GettingHealthy/NutritionCenter/Fish-101_UCM_305986_Article.jsp#aha_recommendation (accessed on 10 August 2015).
138. EFSA (2010); EFSA sets European dietary reference values for nutrient intakes (Online). European Food Safety Authority, Parma, Italy. Available online: http://www.efsa.europa.eu/en/press/news/nda100326.htm (accessed on 15 August 2015).
139. UK SACN. Advice on Fish Consumption: Benefits and Risks; In EDID Collection, Proceedings of the Scientific Advisory Committee on Nutrition, Norwich, UK, 18 June 2004.
140. ISSFAL (2004); Recommendations for Intake of Polyunsaturated Fatty Acids in Healthy Adults (Online). Proceedings of the International Society for the Study of Fatty Acids and Lipids, Brighton, UK. Available online: http://www.issfal.org/statements/pufa-recommendations/statement-3 (accessed on 10 August 2015).
141. Elvevoll, E.O.; Barstad, H.; Breimo, E.S.; Brox, J.; Eilertsen, K.E.; Lund, T.; Olsen, J.O.; Osterud, B. Enhanced incorporation of n-3 fatty acids from fish compared with fish oils. Lipids 2006, 41, 1109–1114.
142. Galli, C.; Marangoni, F. n-3 fatty acids in the Mediterranean diet. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75, 129–133.
143. Visioli, F.; Rise, P.; Barassi, M.C.; Marangoni, F.; Galli, C. Dietary intake of fish vs. formulations leads to higher plasma concentrations of n-3 fatty acids. Lipids 2003, 38, 415–418.